Company guidance, FDA catalysts, dilution risk and cash runway, built from SEC, FDA and ClinicalTrials.gov filings and updated every day.
We send one confirmation email first. Only emails about CYPH, unsubscribe in one click. Privacy
Each summary is written by AI from the filing itself, and one that names a number or a name the filing does not contain is not shown. Quarterly and annual reports are listed by period. Read the filing before acting on it.
CYPH holds $7.6M in cash and short-term investments (as of Jun 30, 2026) and burns about $3.1M/quarter from operations, an estimated runway of 7.5 months at that rate (BioRadar estimate, not company guidance).
Dilution pressure: 75 · High
Recent financing filings on SEC EDGAR:
Source: SEC EDGAR (XBRL cash flow and financing filings). Dilution Watch: every company ranked → · Get an alert when CYPH files for a raise →
| Holder | Type | Shares | % of shares | As of |
|---|---|---|---|---|
| William Patrick III McEvoy Chief Investment Officer, Director, 10% · +98.23M options |
Insider | 29,793,414 | 19.99% | 2026-10-12 |
| Winklevoss Capital Fund, LLC 10% owner · +154.41M options Includes shares also reported by William Patrick III McEvoy, counted once |
Insider | 29,793,414 | 19.99% | 2026-10-12 |
| Severns Sean Michael | 5%+ holder (13G) | 6,000,000 | 4.03% | 2025-11-12 |
| Kevin Zhang Head of Mining · +2.00M options |
Insider | 330,904 | 0.22% | 2026-08-18 |
| James H Cavanaugh Director |
Insider | 168,963 | 0.11% | 2026-03-13 |
| Christian M Richard Director · +75,000 options |
Insider | 168,750 | 0.11% | 2026-03-13 |
| Nissim Mashiach Director · +75,000 options |
Insider | 168,750 | 0.11% | 2026-03-13 |
| William Li Director · +75,000 options |
Insider | 168,750 | 0.11% | 2026-03-13 |
| Richard Schilsky Director |
Insider | 168,750 | 0.11% | 2026-03-13 |
| Joseph Loscalzo Director |
Insider | 168,750 | 0.11% | 2026-03-13 |
| Thomas John Dietz Director · +100,000 options |
Insider | 132,500 | 0.09% | 2026-08-26 |
| Christopher Mirabelli Director |
Insider | 130,376 | 0.09% | 2026-03-26 |
Share count 149,041,593 (latest 10-Q/10-K). Insiders: each officer's, director's and 10% owner's latest Form 3, 4 or 5, direct and indirect shares; options are not counted. 5%+ holders: latest Schedule 13D or 13G of each holder above 5%. Institutions: the total held by all 13F filers (Yahoo Finance); the table lists the largest. Sources have different dates, so the split is approximate. Source: SEC EDGAR.
The 7-day free trial adds AI daily briefings, sentiment tracking, trial enrollment progress and email alerts for CYPH and every other ticker you follow. Card required, cancel anytime.
Start 7-day free trial →